Your browser doesn't support javascript.
loading
Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-year Follow-up of a Prospective Observational Cohort Study.
Smits, Lisa J T; van Esch, Aura A J; Derikx, Lauranne A A P; Boshuizen, Ronald; de Jong, Dirk J; Drenth, Joost P H; Hoentjen, Frank.
Affiliation
  • Smits LJT; Inflammatory Bowel Disease Center, Department of Gastroenterology and Hepatology, Radboud university medical center, Nijmegen, The Netherlands.
  • van Esch AAJ; Inflammatory Bowel Disease Center, Department of Gastroenterology and Hepatology, Radboud university medical center, Nijmegen, The Netherlands.
  • Derikx LAAP; Inflammatory Bowel Disease Center, Department of Gastroenterology and Hepatology, Radboud university medical center, Nijmegen, The Netherlands.
  • Boshuizen R; Department of Gastroenterology and Hepatology, Jeroen Bosch hospital, 's-Hertogenbosch, The Netherlands.
  • de Jong DJ; Biologics Laboratory, Sanquin Diagnostic Services, Amsterdam, The Netherlands.
  • Drenth JPH; Department of Gastroenterology and Hepatology, Jeroen Bosch hospital, 's-Hertogenbosch, The Netherlands.
  • Hoentjen F; Department of Gastroenterology and Hepatology, Jeroen Bosch hospital, 's-Hertogenbosch, The Netherlands.
Inflamm Bowel Dis ; 25(1): 172-179, 2019 01 01.
Article in En | MEDLINE | ID: mdl-29947795

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Agents / Inflammatory Bowel Diseases / Biosimilar Pharmaceuticals / Infliximab / Antibodies, Monoclonal Type of study: Etiology_studies / Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Inflamm Bowel Dis Journal subject: GASTROENTEROLOGIA Year: 2019 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Agents / Inflammatory Bowel Diseases / Biosimilar Pharmaceuticals / Infliximab / Antibodies, Monoclonal Type of study: Etiology_studies / Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Inflamm Bowel Dis Journal subject: GASTROENTEROLOGIA Year: 2019 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom